People living with HIV (PLWH) remain at high risk of mortality and morbidity from vaccine-preventable diseases, even though antiretroviral therapy (ART) has restored life expectancy and general well-being. When, which, and how many doses of vaccine should be administered over the lifetime of PLWH are questions that have become clinically relevant. Immune responses to most vaccines are known to be impaired in PLWH. Effective control of viremia with ART and restored CD4+ T-cell count are correlated with an improvement in responsiveness to routine vaccines. However, the presence of immune alterations, comorbidities and co-infections may alter it. In this article, we provide a comprehensive review of the literature on immune responses to different vaccines in the setting of HIV infection, emphasizing the potential effect of HIV-related factors and presence of comorbidities in modulating such responses. A better understanding of these issues will help guide vaccination and prevention strategies for PLWH.
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus / Tortellini, Eeva; Fosso Ngangue, Yann Collins; Dominelli, Federica; Guardiani, Mariasilvia; Falvino, Carmen; Mengoni, Fabio; Carraro, Anna; Marocco, Raffaella; Pasculli, Patrizia; Mastroianni, Claudio Maria; Ciardi, Maria Rosa; Lichtner, Miriam; Zingaropoli, Maria Antonella. - In: VIRUSES. - ISSN 1999-4915. - 15:9(2023), pp. 1-23. [10.3390/v15091844]
Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus
Tortellini, Eeva
;Fosso Ngangue, Yann Collins;Dominelli, Federica;Guardiani, Mariasilvia;Falvino, Carmen;Mengoni, Fabio;Carraro, Anna;Marocco, Raffaella;Pasculli, Patrizia;Mastroianni, Claudio Maria;Ciardi, Maria Rosa;Lichtner, Miriam;Zingaropoli, Maria Antonella
2023
Abstract
People living with HIV (PLWH) remain at high risk of mortality and morbidity from vaccine-preventable diseases, even though antiretroviral therapy (ART) has restored life expectancy and general well-being. When, which, and how many doses of vaccine should be administered over the lifetime of PLWH are questions that have become clinically relevant. Immune responses to most vaccines are known to be impaired in PLWH. Effective control of viremia with ART and restored CD4+ T-cell count are correlated with an improvement in responsiveness to routine vaccines. However, the presence of immune alterations, comorbidities and co-infections may alter it. In this article, we provide a comprehensive review of the literature on immune responses to different vaccines in the setting of HIV infection, emphasizing the potential effect of HIV-related factors and presence of comorbidities in modulating such responses. A better understanding of these issues will help guide vaccination and prevention strategies for PLWH.File | Dimensione | Formato | |
---|---|---|---|
Tortellini_Immunogenicity_2023 .pdf
accesso aperto
Note: Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
793.85 kB
Formato
Adobe PDF
|
793.85 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.